Real-world outcomes in treatment of highly calcified coronary lesions with intravascular shockwave lithotripsy

Real-world data regarding the efficacy and safety of coronary intravascular lithotripsy (IVL) are lacking. We conducted a study of 50 consecutive patients (64 lesions) who underwent IVL. 3 patients suffered in-hospital mortality unrelated to the IVL; there was no other occurrence of MACE up to 30 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiens, Evan J., Sklar, Jaime C., Wei, Yi Hui, Aleem, Qaiser, Minhas, Kunal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514397/
https://www.ncbi.nlm.nih.gov/pubmed/34627588
http://dx.doi.org/10.1016/j.ihj.2021.09.002
Descripción
Sumario:Real-world data regarding the efficacy and safety of coronary intravascular lithotripsy (IVL) are lacking. We conducted a study of 50 consecutive patients (64 lesions) who underwent IVL. 3 patients suffered in-hospital mortality unrelated to the IVL; there was no other occurrence of MACE up to 30 days. Angiographic success was nearly universal (98% of patients with residual stenosis <50%, 96% of patients with TIMI 3 flow) and complication was rare, including among patients undergoing IVL for in-stent restenosis or left main coronary artery lesions. In a high-risk real-world cohort, IVL was a safe and effective treatment for highly-calcified coronary lesions.

Ejemplares similares